GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » Earnings per Share (Diluted)

Tourmaline Bio (Tourmaline Bio) Earnings per Share (Diluted) : $-1.58 (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio Earnings per Share (Diluted)?

Tourmaline Bio's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.55. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.58.

Tourmaline Bio's EPS (Basic) for the three months ended in Mar. 2024 was $-0.55. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.58.

Tourmaline Bio's EPS without NRI for the three months ended in Mar. 2024 was $-0.55. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.61.

During the past 12 months, Tourmaline Bio's average EPS without NRIGrowth Rate was -456.70% per year.


Tourmaline Bio Earnings per Share (Diluted) Historical Data

The historical data trend for Tourmaline Bio's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio Earnings per Share (Diluted) Chart

Tourmaline Bio Annual Data
Trend Dec21 Dec22 Dec23
Earnings per Share (Diluted)
- -0.97 -8.87

Tourmaline Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only -0.37 -0.79 -0.35 0.11 -0.55

Competitive Comparison of Tourmaline Bio's Earnings per Share (Diluted)

For the Biotechnology subindustry, Tourmaline Bio's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tourmaline Bio's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's PE Ratio distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's PE Ratio falls into.



Tourmaline Bio Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Tourmaline Bio's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-42.124-0)/4.747
=-8.87

Tourmaline Bio's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-13.311-0)/24.082
=-0.55

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Tourmaline Bio  (NAS:TRML) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tourmaline Bio Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tourmaline Bio (Tourmaline Bio) Business Description

Traded in Other Exchanges
N/A
Address
27 West 24th Street, Suite 702, New York, NY, USA, 10010
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.